prednisone has been researched along with Lacrimal Duct Obstruction in 3 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Lacrimal Duct Obstruction: Interference with the secretion of tears by the lacrimal glands. Obstruction of the LACRIMAL SAC or NASOLACRIMAL DUCT causing acute or chronic inflammation of the lacrimal sac (DACRYOCYSTITIS). It is caused also in infants by failure of the nasolacrimal duct to open into the inferior meatus and occurs about the third week of life. In adults occlusion may occur spontaneously or after injury or nasal disease. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p250)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The other two patients developed nasolacrimal duct obstructions at 4 and 11 months after completion of RT." | 1.36 | Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma). ( Choi, BO; Choi, IB; Hong, YS; Kim, GW; Kim, YS; Son, SH; Yang, SW, 2010) |
| "Oral prednisone was administered for five days after surgery." | 1.29 | Balloon catheter dilatation for treatment of congenital nasolacrimal duct obstruction. ( Becker, BB; Berry, FD; Koller, H, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Son, SH | 1 |
| Choi, BO | 1 |
| Kim, GW | 1 |
| Yang, SW | 1 |
| Hong, YS | 1 |
| Choi, IB | 1 |
| Kim, YS | 1 |
| Peter, NM | 1 |
| Khooshabeh, R | 1 |
| Becker, BB | 1 |
| Berry, FD | 1 |
| Koller, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Long Term Follow up of Nasolacrimal Intubation in Adults With Mild Epiphora[NCT00706251] | 180 participants (Actual) | Observational | 2000-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for prednisone and Lacrimal Duct Obstruction
| Article | Year |
|---|---|
Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cataract; Conjunctival Neoplasms; Cyclo | 2010 |
Low-grade systemic lymphoma with aggressive transformation in the lacrimal sac.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cell Transfo | 2012 |
Balloon catheter dilatation for treatment of congenital nasolacrimal duct obstruction.
Topics: Anti-Inflammatory Agents; Catheterization; Child; Child, Preschool; Eye Infections; Female; Follow-U | 1996 |